Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Mullick

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wallAdam E Mullick, Richard J Deckelbaum, Ira J Goldberg, et al.
American Journal of Translational Research|January 13, 2021
Endothelial cell CD36 deficiency prevents normal angiogenesis and vascular repairLara Bou Khzam, Ni-Huiping Son, Adam E Mullick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injuryAdam E Mullick, James M McDonald, Goar Melkonian, et al.
Human Molecular Genetics|May 22, 2014
An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2Kameswaran Ravichandran, Iram Zafar, Zhibin He, et al.
Molecular Therapy. Nucleic Acids|December 2, 2015
CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney InflammationAaron J Donner, Steve T Yeh, Gene Hung, et al.
Journal of Lipid Research|August 9, 2021
Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in miceThomas A Bell, Mingxia Liu, Aaron J Donner, et al.
The Journal of Experimental Medicine|February 6, 2008
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic eventsAdam E Mullick, Katrin Soldau, William B Kiosses, et al.
Hypertension (Dallas, Tex. : 1979)|July 19, 2017
Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney InjuryAdam E Mullick, Steve T Yeh, Mark J Graham, et al.
Hypertension (Dallas, Tex. : 1979)|July 17, 2020
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19Congqing Wu, Dien Ye, Adam E Mullick, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19Congqing Wu, Dien Ye, Adam E Mullick, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wallAdam E Mullick, Richard J Deckelbaum, Ira J Goldberg, et al.
American Journal of Translational Research|January 13, 2021
Endothelial cell CD36 deficiency prevents normal angiogenesis and vascular repairLara Bou Khzam, Ni-Huiping Son, Adam E Mullick, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2002
Reactive carbonyls from tobacco smoke increase arterial endothelial layer injuryAdam E Mullick, James M McDonald, Goar Melkonian, et al.
Human Molecular Genetics|May 22, 2014
An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2Kameswaran Ravichandran, Iram Zafar, Zhibin He, et al.
Molecular Therapy. Nucleic Acids|December 2, 2015
CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney InflammationAaron J Donner, Steve T Yeh, Gene Hung, et al.
Journal of Lipid Research|August 9, 2021
Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in miceThomas A Bell, Mingxia Liu, Aaron J Donner, et al.
The Journal of Experimental Medicine|February 6, 2008
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic eventsAdam E Mullick, Katrin Soldau, William B Kiosses, et al.
Hypertension (Dallas, Tex. : 1979)|July 19, 2017
Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney InjuryAdam E Mullick, Steve T Yeh, Mark J Graham, et al.
Hypertension (Dallas, Tex. : 1979)|July 17, 2020
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19Congqing Wu, Dien Ye, Adam E Mullick, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19Congqing Wu, Dien Ye, Adam E Mullick, et al.
Pageof 9